Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions (Q42932794)

11 November 2017

Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions (English)

1 reference

11 November 2017

1 reference

Md Shenuarin Bhuiyan

1

1 reference

11 November 2017

Hideaki Tagashira

series ordinal

2

1 reference

11 November 2017

Norifumi Shioda

series ordinal

3

1 reference

11 November 2017

Kohji Fukunaga

series ordinal

4

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Therapeutic Targets

11 November 2017

1 reference

11 November 2017

14

1 reference

11 November 2017

10

1 reference

11 November 2017

1009-1022

1 reference

Sigma receptors: potential medications development target for anti-cocaine agents

11 November 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Apparent desensitization of the effects of sigma receptor ligand haloperidol in isolated rat and guinea pig hearts after chronic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Stimulation of sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Stimulation of Sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Neurosteroids: a novel function of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

In vitro and in vivo binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Imaging sigma receptors: applications in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Activation of endothelial nitric oxide synthase by a vanadium compound ameliorates pressure overload-induced cardiac injury in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Characterization of an animal model of postmenopausal cardiac hypertrophy and novel mechanisms responsible for cardiac decompensation using ovariectomized pressure-overloaded rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

p-chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Fluvoxamine and sigma-1 receptor agonists dehydroepiandrosterone (DHEA)-sulfate induces the Ser473-phosphorylation of Akt-1 in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Silencing of sigma-1 receptor induces cell death in human lens cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

MAM: more than just a housekeeper

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Regulating ankyrin dynamics: Roles of sigma-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Sertraline treatment of major depression in patients with acute MI or unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Paroxetine modulates psychological and sympathetic responses during public speaking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

Selective serotonin reuptake inhibitors and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2010.509348

10.1517/14728222.2010.509348

21 January 2018

Identifiers

DOI

1 reference

11 November 2017

1 reference